Buy Like Buffett
Watchlist

Flagship explainer

How INTERPACE BIOSCIENCES, INC. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$38.7M · 100%Cost of revenue$14.6M · 38%Gross profit$24.1M · 62%Operating income$4.1M · 11%Income before tax$3.8M · 10%Income tax−$21.2M · −55%Net income$24.6M · 63%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$38.7M100%
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-013646 · filed Mar 30, 2026
Cost of revenue$14.6M38%
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-013646 · filed Mar 30, 2026
$24.1M62%
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-013646 · filed Mar 30, 2026
$4.1M11%
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-013646 · filed Mar 30, 2026
Income before tax$3.8M10%
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-013646 · filed Mar 30, 2026
Income tax−$21.2M−55%
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-013646 · filed Mar 30, 2026
$24.6M63%
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-013646 · filed Mar 30, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-013646 · filed Mar 30, 2026
· event Dec 31, 2025 · retrieved Oct 17, 2026 · annual-row source set
Embed this chart

View the full INTERPACE BIOSCIENCES, INC. analysis at Buy Like Buffett